The Fc-alpha receptor is a new target antigen for immunotherapy of myeloid leukemia.
Mladenov R, Hristodorov D, Cremer C, Hein L, Kreutzer F, Stroisch T, Niesen J, Brehm H, Blume T, Brümmendorf TH, Jost E, Thepen T, Fischer R, Stockmeyer B, Barth S, Stein C.
Mladenov R, et al. Among authors: stein c.
Int J Cancer. 2015 Dec 1;137(11):2729-38. doi: 10.1002/ijc.29628. Epub 2015 Jun 12.
Int J Cancer. 2015.
PMID: 26041304